$0.22 EPS Expected for Medidata Solutions, Inc. (MDSO) on July, 17

June 27, 2018 - By Gregory Tomko

Medidata Solutions, Inc. (NASDAQ:MDSO) Corporate Logo
Big Money Sentiment decreased to 0.95 in Q1 2018. It has change of 0.76, from 2017Q4’s 1.71. The ratio worsened due to Medidata Solutions, Inc. positioning: 36 sold and 74 reduced. 28 funds acquired holdings and 76 increased holdings. Investors holded 61.06 million in 2017Q4 but now own 62.26 million shares or 1.96% more.
Northern Trust accumulated 894,696 shs or 0.01% of the stock. Moreover, Massachusetts Finance Ma has 0.01% invested in Medidata Solutions, Inc. (NASDAQ:MDSO) for 223,341 shs. 7,686 were reported by Trexquant Inv L P. Jpmorgan Chase & invested in 1.34M shs. Comerica Financial Bank holds 61,772 shs. Raymond James & owns 36,542 shs or 0% of their US capital. Champlain Investment Ptnrs Ltd Liability Corporation has 2.15M shs. State Street Corp accumulated 1.91 million shs. New Mexico Educational Retirement Board has 16,100 shs for 0.04% of their capital. Commercial Bank Of New York Mellon stated it has 1.62M shs. Parametric Portfolio Ltd Liability Company accumulated 79,779 shs or 0% of the stock. Delta Asset Mngmt Lc Tn has invested 0% in Medidata Solutions, Inc. (NASDAQ:MDSO). 781,988 were accumulated by State Common Retirement Fund. Sumitomo Mitsui Asset Mgmt reported 49,008 shs. New York-based Tiaa Cref Mngmt Limited Liability has invested 0.01% in Medidata Solutions, Inc. (NASDAQ:MDSO).

Medidata Solutions, Inc. registered $6.22 million net activity with 0 insider purchases and 12 sales since January 19, 2018. On Friday, January 19 Shares for $132,920 were sold by Bergmann Rouven. TAYLOR ROBERT had sold 3,630 shs worth $285,681. Otner Michael I. also sold $728,170 worth of Medidata Solutions, Inc. (NASDAQ:MDSO) on Wednesday, April 25. On Monday, March 12 Sherif Tarek sold $1.89 million worth of Medidata Solutions, Inc. (NASDAQ:MDSO).

Earnings report for Medidata Solutions, Inc. (NASDAQ:MDSO) is awaited on July, 17., according to RTT. Analysts have anticipation on stock’s earnings per share of $0.22. That’s up 22.22 % from last year’s $0.18 earnings per share. The profit will be $13.02M for MDSO if $0.22 earnings per share becomes true. After $0.24 EPS report previous quarter, Wall Street now sees -8.33 % negative EPS growth of Medidata Solutions, Inc.. MDSO is touching $79.43 during the last trading session, after increased 0.12%.Medidata Solutions, Inc. has volume of 26,162 shares. Since June 27, 2017 MDSO has risen 4.39% and is uptrending. MDSO underperformed by 8.18% the S&P500.

Medidata Solutions, Inc. (NASDAQ:MDSO) Ratings Coverage

A total of 10 analysts rate Medidata Solutions (NASDAQ:MDSO) as follows: 6 “Buy”, 4 “Hold” and 0 “Sell”. Тherefore 60% are bullish. (NASDAQ:MDSO) has 14 ratings reports on Jun 27, 2018 according to StockzIntelligence. On Friday, April 20 Needham maintained Medidata Solutions, Inc. (NASDAQ:MDSO) rating. Needham has “Buy” rating and $8000 target. The stock rating was maintained by Dougherty with “Buy” on Thursday, May 10. The stock rating was maintained by Deutsche Bank with “Buy” on Thursday, May 31. On Thursday, February 8 the rating was maintained by RBC Capital Markets with “Hold”. The company rating was maintained by Piper Jaffray on Wednesday, May 23. On Monday, May 21 the firm has “Equal-Weight” rating by Morgan Stanley given. On Monday, January 22 the firm earned “Buy” rating by SunTrust. On Thursday, February 8 the stock of Medidata Solutions, Inc. (NASDAQ:MDSO) earned “Buy” rating by Piper Jaffray. On Tuesday, June 12 Piper Jaffray maintained Medidata Solutions, Inc. (NASDAQ:MDSO) with “Buy” rating. In Wednesday, January 3 report KeyBanc Capital Markets maintained the stock with “Buy” rating.

Medidata Solutions, Inc. provides cloud solutions for life sciences worldwide.The firm is valued at $4.70 billion. It offers Medidata Clinical Cloud that provides a software-as-a-service platform of technology and data analytics solutions to optimize activities across clinical development.107.48 is the P/E ratio. The companyÂ’s platform solutions includes Plan Study that addresses the areas to ensure optimal study design, grant development and negotiation, and investigator payments; and Support Sites, which provides robust risk management, reduced source document verification, real-time monitoring, on-time, accurate payments.

More recent Medidata Solutions, Inc. (NASDAQ:MDSO) news were announced by Streetinsider.com, Seekingalpha.com and Businesswire.com. The first one has “Medidata Solutions (MDSO) PT Raised to $85 at Deutsche Bank” as a title and was announced on May 31, 2018. The next is “Medidata Solutions acquires SHYFT Analytics for $195M in cash” on June 12, 2018. And last was announced on June 25, 2018, called “Clinical Research Can Now Be Truly Patient-Centric By Quantifying Patient Burden with Medidata”.

Medidata Solutions, Inc. (NASDAQ:MDSO) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.